adcom

Rigel Pharmaceuticals

trial

It can halt trials to protect volunteers from unreasonable risk of illness or injury or because a study’s design is deficient.

Placebo data for their trial is downright terrible.

Yea management screwed up not pivoting sooner after the phase 2.

volume

Sounds like a good buy .but no volume and it faded

shit

FUCK YOU RAUL for destroying my confidence and making me fearful of ever investing again in biotechs.

$RIGL What a shit show…goes back sub 1$

$RIGL The most boring price action all fucking day.

$RIGL absolute toast they fucking killes this one

but holy hell they didn&#39;t seem to give a crap about the notice of delisting.

executive

$RIGL can  someone  please  explain  all  the  back  and  forth  power  of  attorney  documents  between  officers?

the bad mgmt, the bad CEO, oh boo hoo, what shall I do .

Better would be a major change in executives, and some actual performance.

news

Rezlidhia is likely to have many potential indications and the best news is that it&#39;s approved and the patent life is very long.

Good news like this is typically when biotech is a risk off scenario.

$RIGL Best news from the Conference Call in my opinion.

$RIGL need more good news to add fuel to the fire and get this back over $3 cmon Rigel💪

$RIGL The volume increased for one day, resulting in a record-breaking daily growth of 550% of the 65-Day Volume Moving Average.

$RIGL lets see $2 today 👀  unusually high pre market volume.. something great on the way

$RIGL 40% volume in less than a hour 😎🤑

$RIGL volumes picking up I’d like to see a 15 million day 🤑😎

$RIGL Good volume going again today so far.

$RIGL million volume already lfg baby 😎🤑

📈 Scan as of now “RUNNERS WITH HIGH RELATIVE VOLUME” 12/02/2022 
 
$COSM #1 on the scanner with 173.8 million shares traded and up by 27.5%, $RIGL #2 with 42.9 million shares traded and up by 23.53%  
 
Good luck everyone 🍀

$RIGL prime take over target and strong future sales means I win big time and I have a couple of year to wait.

$RIGL look at those big bids coming back 🤣

$RIGL, I have a feeling that this is the beginning of a very big movement.

$RIGL miracle drug with more opportunities coming in the oncology space 💪 big upside ahead

&quot;Activity has picked up in recent months, and signs point to a strong year ahead  
This year was supposed to be a big one for healthcare deals.

&quot;Activity has picked up in recent months, and signs point to a strong year ahead 
This year was supposed to be a big one for healthcare deals.

share

been holding 1 share for ever n see it&#39;s up 2%.

$RIGL 13.49 more a share Florida lfg 😎🤑

Buy and just stash your shares away in a safe!! 😂😂😂

$RIGL My biggest regret is not buying enough shares 🤦 I should have cut my losses other places and put it all in here 💚

$RIGL dang shares are locked with strong hands

@minamargroup The stock market last week saw a nice movement in $RIGL share prices.

$RIGL  so glad I bought this back more shares too

Acer Therapeutics Inc

price

$ACER oufffff, a private placement at the price of 1.16 the ordinary share, it is disastrous for the shareholders.

$ACER ouffff, a private placement at the price of 1.16 the ordinary share, it is disastrous for the shareholders.

$ACER Target prices are usually completely nonsense.

$ACER https://www.intratio.com/stock-forecast/ACER Our network computed this company s stock price has a rather grim outlook for the immediate future and, in the long run, faces severe disadvantages

Why list the price at 1.18 if it isnt even reasonably close to true?

With the positive adcom we see a lower risk of denial.

$ACER Zack&#39;s has a strong buy signal across the board for this

Consensus Rating 
Acer Therapeutics has received a consensus rating of Buy.

$ACER Acer Therapeutics Inc. (ACER) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy).

$ACER Acer Therapeutics Inc. (ACER) Upgraded to Strong Buy:

therapeutic

$ACER Zack is showing this again today, 
The stock of Acer Therapeutics has risen 19.5% in the past one year.

$ACER Acer Therapeutics Inc. (ACER Quick QuoteACER - Free Report) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy).

$ACER What a beautiful price before partnership news, sales launch news and p2a data.

$ACER Good news If any, is the volume is picking up.

$ACER holding this for positive movement--let&#39;s get some good news! !

$ACER good time to load some before FDA news on Sunday. 👌

$ACER Starting to move with all the good news, that has been coming out.

$ACER  these are  all good news then what with the manipulations . !!

buying

So to the ones that done there research knows this is a great buying opportunity.

$ACER $MTTR excellent buying opportunity for both!! 💪🚀

$ACER  
 
2.70 still a great entry as thus stock held ~$2.50 strongly 
 
Low risk at this price point, smart money knows that and will be buying 😎

Chart looks really good, insiders buying and we have alow float of 11 million.

$ACER Insiders buying 1 
million and 500k… $KTRA  $PHAT $GMDA Chart looks great take a look.

$ACER  
 
movement on insider buying, PDUFA, and enough money to get by -- nice

Rhythm Pharmaceuticals Inc.

Easy 3x to 4x upon a positive adcom vote.

Top Stocks matching your search for "adcom future"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

RIGL

Rigel Pharmaceuticals

-16.67%

$1.68 - $1.40

Jan, 25, 2023

ACER

Acer Therapeutics Inc

-64.37%

$2.22 - $0.79

Jan, 25, 2023

Jan, 25, 2023

RYTM

Rhythm Pharmaceuticals Inc.

-39.42%

$29.53 - $17.89

Oct, 31, 2022

RIGL

Rigel Pharmaceuticals

-16.67%

$1.68 - $1.40

Jan, 25, 2023

ACER

Acer Therapeutics Inc

-64.37%

$2.22 - $0.79

Jan, 25, 2023

Jan, 25, 2023

RYTM

Rhythm Pharmaceuticals Inc.

-39.42%

$29.53 - $17.89